TOSHIBA’S NEWEST ULTRASOUND SYSTEMS OFFER BREAKTHROUGH IMAGING TECHNOLOGIES AND ADVANCED CARDIAC CAPABILITIES
TOSHIBA’S NEWEST ULTRASOUND SYSTEMS OFFER BREAKTHROUGH IMAGING TECHNOLOGIES AND ADVANCED CARDIAC CAPABILITIES. Toshiba to Highlight Aplio 500 and Aplio 300; Enhancements to Aplio Artida’s 3D Imaging Capabilities at ACC Annual Meeting
Wed Mar 21 2012
CHICAGO, March 22, 2012
TOSHIBA’S NEWEST ULTRASOUND SYSTEMS OFFER BREAKTHROUGH IMAGING TECHNOLOGIES AND ADVANCED CARDIAC CAPABILITIES
Toshiba to Highlight Aplio 500 and Aplio 300;
Enhancements to Aplio Artida’s 3D Imaging Capabilities at ACC Annual Meeting
Improving the ability to diagnose cardiac disease with advanced ultrasound imaging, Toshiba America Medical Systems, Inc. will showcase the newest additions to its ultrasound product line, AplioTM 500 and Aplio 300 at this year’s American College of Cardiology (ACC) annual meeting in Chicago, March 24 – 27, 2012 . Toshiba will also introduce new enhancements to its Aplio ArtidaTM flagship cardiac ultrasound.
Toshiba’s Aplio 500 brings quantitative cardiac analysis bedside and is the system of choice for all 2D cardiac imaging needs. Aplio 500 features Toshiba’s Wall Motion Tracking technology, combined with superior ergonomics and a smaller footprint, making it easier to maneuver for greater patient access and improved workflow. Toshiba’s new high-end shared- service ultrasound system, Aplio 300, offers exceptional image quality in a versatile platform designed for routine ultrasound exams, including cardiac.
Aplio Artida’s new software version 3.0 offers improved 3D imaging and next-generation 3D Wall Motion Tracking software, which provide accurate and reproducible quantitative analysis of cardiac function. In addition, the Artida’s enhanced single-beat 3D acquisition allows physicians to obtain high-quality 3D images with detailed 3D Wall Motion Tracking analysis on a wider range of patients, including those with arrhythmias and shortness of breath.
“Aplio Artida’s 3D Wall Motion Tracking capability enables clinicians to assess live 3D volume images in one cardiac cycle, allowing physicians to get their clinical information faster, even on technically difficult patients,” said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba. “Combining the dedicated cardiac system, Aplio Artida, with the new Aplio 500 and 300 gives Toshiba a complete cardiac ultrasound portfolio for virtually any imaging need.”